Park Avenue Securities’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,795
Closed -$187K 1695
2025
Q2
$187K Buy
+11,795
New +$176K ﹤0.01% 1436
2024
Q2
Sell
-7,925
Closed -$263K 1421
2024
Q1
$263K Sell
7,925
-134
-2% -$4.58K ﹤0.01% 1222
2023
Q4
$287K Sell
8,059
-1,109
-12% -$35.2K ﹤0.01% 1141
2023
Q3
$313K Buy
+9,168
New +$349K ﹤0.01% 1025
2022
Q3
Sell
-6,403
Closed -$229K 1175
2022
Q2
$229K Buy
6,403
+280
+5% +$11.3K ﹤0.01% 1019
2022
Q1
$301K Buy
6,123
+1,075
+21% +$56.8K 0.01% 951
2021
Q4
$282K Buy
5,048
+668
+15% +$36.7K 0.01% 940
2021
Q3
$254K Buy
4,380
+194
+5% +$12K 0.01% 918
2021
Q2
$265K Buy
4,186
+427
+11% +$28.1K 0.01% 892
2021
Q1
$240K Buy
+3,759
New +$218K 0.01% 864
2020
Q1
Sell
-4,720
Closed -$267K 625
2019
Q4
$267K Buy
+4,720
New +$263K 0.01% 498

Other funds holding XRAY

Park Avenue Securities's XRAY Position: Q3 2025 in Review

Park Avenue Securities sold out of Dentsply Sirona (XRAY) in Q3 2025, closing a stake of 11,795 shares — an estimated $187K sold.

Park Avenue Securities first reported a position in XRAY in Q4 2019 and held it in 11 quarters. The position peaked at $313K in Q3 2023. 411 funds tracked by Wall St. Rank hold XRAY as of Q3 2025.

  • Park Avenue Securities reported no remaining Dentsply Sirona position as of Q3 2025 after selling out during the quarter.
  • Park Avenue Securities sold 11,795 Dentsply Sirona shares in Q3 2025, an estimated $187K.
  • Park Avenue Securities first reported a position in Dentsply Sirona in Q4 2019 and held it in 11 quarters.
  • Park Avenue Securities's Dentsply Sirona position peaked at $313K in Q3 2023.
  • 411 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2025.

Based on Park Avenue Securities's 13F filing for Q3 2025, filed 23 Oct 2025.